Tricuspid Valve Insufficiency clinical trials at UCSF
3 in progress, 1 open to eligible people
Tricuspid valve insufficiency is when the tricuspid valve does not close and blood leaks backward in the heart. UCSF is testing a catheter device that repairs the valve without open heart surgery. UCSF is measuring safety and valve function after the repair.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
San Francisco, California and other locations
TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.
Sorry, not yet accepting patients
Pivotal trial to evaluate the safety and effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System.
San Francisco, California and other locations
TRISCEND II Pivotal Trial
Sorry, in progress, not accepting new patients
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
San Francisco, California and other locations
Our lead scientists for Tricuspid Valve Insufficiency research studies include Sammy Elmariah, MD.
Last updated: